The primary market will remain in focus as Jio Platforms Ltd. and Paras Healthcare Ltd. open their public issues for subscription on October 21, according to reports from The Week Ahead. Jio Platforms' ₹30,213 crore IPO comprises an entirely fresh issue of 27 crore shares priced in the range of ₹1,065-1,119 apiece. The issue requires investors to bid for a minimum of 12 shares, translating into an investment of ₹13,428 at the upper end of the price band. Paras Healthcare is looking to raise ₹1,450 crore through a combination of a ₹500 crore fresh issue and a ₹950 crore offer for sale, priced at ₹660-693 per share with a minimum application size of 21 shares. The basis of allotment for both IPOs is expected to be finalised on October 26, while shares are slated to list on the NSE and BSE on October 28. As per latest reports, anchor investors get their first look on Monday, while everyday retail buyers can bid through Friday, 23 October, with a special ₹2,500 crore quota set aside specifically for current Reliance Industries shareholders.
The subscription patterns reveal stark differences in investor interest between the two mainboard IPOs. Jio Platforms witnessed strong investor interest, with overall subscription exceeding five times, according to exchange data. Qualified institutional buyers (QIBs) led the demand, subscribing to their allotted portion 13.29 times, while the retail investor segment was subscribed 1.35 times and the non-institutional investor (NII) category received 5.97 times subscription on the second day of bidding. In contrast, Paras Healthcare's ₹1,450-crore IPO saw a relatively subdued response, with the issue subscribed just 0.34 times by the close of bidding on October 22. Retail investors showed comparatively stronger participation, with their portion subscribed 1.31 times, while demand remained weak in the NII segment, which was subscribed 0.25 times.
The grey market premium trends show a wide gap in investor sentiment, with Reliance Jio Platforms commanding a substantially higher premium than Paras Healthcare. According to Investorgain, Reliance Jio Platforms IPO GMP stood at ₹240 per share on the last day of bidding, implying a premium of approximately 21.45% over the upper price band of ₹1,119. Meanwhile, Paras Healthcare's GMP fell to ₹13 from ₹25 on October 21, suggesting a much more modest expected listing gain. Based on their latest available GMPs and upper price bands, Reliance Jio Platforms appears to have a stronger indicative listing premium than Paras Healthcare. For Jio Platforms, the estimated listing price of ₹1,359 represents a potential gain of ₹240 per share or 21.45% over the upper issue price of ₹1,119, while for Paras Healthcare, the estimated listing price of ₹706 implies a potential gain of ₹13 per share or 1.88% over the upper price band of ₹693.
Investors will await the minutes of the Reserve Bank of India's latest Monetary Policy Committee meeting on October 21, as reported by The Week Ahead. The minutes will provide detailed account of policymakers' views on inflation, economic growth, liquidity conditions and the interest-rate outlook. Market participants will look for any divergence in views among committee members and assess the central bank's stance on domestic and global risks. At its October meeting, the MPC unanimously raised the repo rate by 25 basis points (bps) to 5.5%, but its decision to shift from a neutral to a calibrated tightening stance was split 4-2. The minutes will offer an insight into why two members favoured retaining the neutral stance and how the committee weighed inflation against growth. RBI last adopted calibrated tightening eight years ago under Urjit Patel, amid inflationary pressures. It shifted to an accommodative stance in June 2019 as inflation eased and growth slowed, retaining it until March 2022.
Indian stock exchanges will remain closed on October 22 on account of Dussehra, resulting in a shortened trading week and potentially keeping trading activity subdued around the break, according to The Week Ahead. The holiday will also keep investors tracking major global developments scheduled during the market holiday. Investors are also likely to track weekly US initial jobless claims data on October 22 for fresh signals on the health of the labour market, with economists expecting claims at 200,000 compared with 199,000 in the previous week. The data will be assessed for clues on economic resilience and the potential path of Federal Reserve policy.
Corporate earnings will remain a key market driver this week with several companies slated to announce September-quarter results, as reported by The Week Ahead. On Monday, investors will track earnings from Bajaj Finance, Hindustan Zinc, UltraTech Cement, Union Bank of India, L&T Technology Services, Indian Renewable Energy Development Agency, Piramal Finance, Delta Corp, Just Dial, Sobha, HFCL and Waaree Renewable Technologies. Results from lenders and financial services firms such as Bajaj Finance, Union Bank of India and Piramal Finance will provide insights into credit growth, asset quality and consumer demand trends. Commentary from UltraTech Cement, Hindustan Zinc and other industrial companies will offer clues on infrastructure activity, commodity demand and margin trends.
Attention will shift to flash purchasing managers' index readings for October on October 23, tracking both the US Manufacturing PMI and Services PMI reports for indications of business activity across the world's largest economy, according to The Week Ahead. The readings will offer insights into demand trends and economic momentum heading into the final quarter of the year. The data could influence expectations around growth, interest rates and risk appetite across global markets.
